Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Net Income (2021 - 2026)

Zymeworks (ZYME) posted Net Income of -$44.2 million for Q1 2026, down 7.17% sequentially from -$41.2 million in Q4 2025, and down 95.1% YoY from -$900.6 million in Q1 2025.

Analysis

Zymeworks (ZYME) Net Income (2021 - 2026) Analysis & Trends

Zymeworks has reported Net Income for 6 years, with the latest figure at -$44.2 million in Q1 2026.

  • Quarterly Net Income fell 95.1% year-over-year to -$44.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$102.7 million (up 9.7% YoY) and the FY2025 annual result came in at -$81.1 million, up 33.88% from the prior year.
  • Net Income declined to -$44.2 million in Q1 2026 per ZYME's latest filing, from -$41.2 million in the prior quarter.
  • Over five years, Net Income peaked at $309.4 million in Q4 2022 and troughed at -$72.6 million in Q1 2022.
  • A 5-year average of -$14.3 million and a median of -$29.8 million in 2024 frame the typical range for Net Income.
  • The sharpest annual moves came in 2022 and 2023: Net Income jumped 890.33% in 2022, then plunged 104.68% in 2023.
  • Over 5 years, Net Income stood at $309.4 million in 2022, then slumped by 104.68% to -$14.5 million in 2023, then tumbled by 62.31% to -$23.5 million in 2024, then slumped by 75.31% to -$41.2 million in 2025, then decreased by 7.17% to -$44.2 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$44.2 million, -$41.2 million, and -$19.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -13.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - -45.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -45.02 Mn
Mar 31, 2026 -44.16 Mn
Dec 31, 2025 -41.21 Mn
Sep 30, 2025 -19.60 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 -22.64 Mn
Dec 31, 2024 -23.51 Mn
Sep 30, 2024 -29.85 Mn
Jun 30, 2024 -37.69 Mn
Mar 31, 2024 -31.65 Mn
Dec 31, 2023 -14.48 Mn
Sep 30, 2023 -28.69 Mn
Jun 30, 2023 -51.15 Mn
Mar 31, 2023 -24.35 Mn
Dec 31, 2022 309.43 Mn
Sep 30, 2022 -47.85 Mn
Jun 30, 2022 -64.62 Mn
Mar 31, 2022 -72.63 Mn
Dec 31, 2021 -39.15 Mn
Sep 30, 2021 -60.58 Mn